Drugs by condition
Drugs approved for ankylosing spondylitis
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
48
Still marketed, NDA or BLA
Drug classes
8
Novel drugs
14
New molecular entities and new biologics
In development
10
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for ankylosing spondylitis.
All approved drugs for ankylosing spondylitis, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 223 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Tumor Necrosis Factor Blocker (12)
- Simponi Golimumab · Centocor Ortho Biotech INC · 2009
- Cimzia Certolizumab Pegol · Ucb INC · 2008
- Enbrel Etanercept · Immunex · 1998
- Remicade Infliximab · Centocor INC · 1998
- Yusimry Adalimumab-Aqvh · Emerge Bioscience Pte LTD · 2021
- Avsola Infliximab-Axxq · Amgen INC · 2019
- Hadlima Adalimumab-Bwwd · Samsung Bioepis CO LTD · 2019
- Hyrimoz Adalimumab-Adaz · Sandoz INC · 2018
- Renflexis Infliximab-Abda · Samsung Bioepis CO LTD · 2017
- Amjevita Adalimumab-Atto · Amgen INC · 2016
- Inflectra Infliximab-Dyyb · Celltrion INC · 2016
- Simponi Aria Golimumab · Janssen Biotech · 2013
Nonsteroidal Anti-inflammatory Drug (6)
- Celebrex Celecoxib · Upjohn · 1998
- Vyscoxa Celecoxib · Carwin Pharm Assoc · 2025
- Ec-Naprosyn Naproxen · Atnahs Pharma US · 1994
- Naprosyn Naproxen · Atnahs Pharma US · 1987
- Indocin Indomethacin · Cosette · 1985
- Indomethacin Indomethacin · Chartwell Molecules · 1984
Interleukin-17A Antagonist (3)
Corticosteroid (3)
- Medrol Methylprednisolone · Pfizer · 1957
- Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
- Cortef Hydrocortisone · Pharmacia and Upjohn · 1952
Janus Kinase Inhibitor (2)
Antirheumatic Agent (2)
Adrenocorticotropic Hormone (2)
- Purified Cortrophin Gel Corticotropin · Ani Pharms · 1954
- Acthar Gel Corticotropin · Mallinckrodt Ireland · 1952
Class not listed in FDA's data (18)
- Bimzelx Bimekizumab-Bkzx · Ucb INC · 2023
- Xeljanz Tofacitinib Citrate · Pf Prism Cv · 2012
- Humira Adalimumab · Abbvie INC · 2002
- Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
- Simlandi Adalimumab-Ryvk · Alvotech USA INC · 2024
- Idacio Adalimumab-Aacf · Fresenius Kabi USA · 2024
- Yuflyma Adalimumab-Aaty · Celltrion · 2023
- Xeljanz Tofacitinib Citrate · Pfizer · 2020
- Hulio Adalimumab-Fkjp · Mylan Pharms INC · 2020
- Abrilada Adalimumab-Afzb · Pfizer INC · 2019
- Cyltezo Adalimumab-Adbm · Boehringer Ingelheim · 2017
- Xeljanz Xr Tofacitinib Citrate · Pfizer · 2016
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Naprelan Naproxen Sodium · Twi Pharms · 1996
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
- Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
- Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
- Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955
Drugs in development for ankylosing spondylitis
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- MK-7240PRA023, TulisokibartPhase 310 trials
Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease
- FilgotinibGS-6034, GLPG0634Phase 36 trials
Alfasigma S.p.A. · Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis (JIA)
- VC005Phase 35 trials
Jiangsu vcare pharmaceutical technology co., LTD · Non-segmental Vitiligo, Non-Segmental Vitiligo, Atopic Dermatitis
- Jaktinib HydrochloridePhase 34 trials
Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Atopic Dermatitis, Ankylosing Spondylitis
- LNK01001Phase 33 trials
Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis
- SHR-1314Phase 33 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Active Non-radiographic Axial Spondyloarthritis, Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis, Psoriatic Arthritis
- AK111Phase 32 trials
Akeso · Psoriasis, Skin Diseases, Ankylosing Spondylitis
- HS_SW01 cellsHS_SW01Phase 23 trials
Shenzhen Huishan Biotechnology Co., Ltd. · Ankylosing Spondylitis, Primary Ovarian Insufficiency (Poi), Systemic Sclerosis (SSc)
- SPY002-072SPY072Phase 22 trials
Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis
- vilamakitugXB2001, NatrunixPhase 22 trials
XBiotech, Inc. · Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpA
More on ankylosing spondylitis: recruiting trials · published research
Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Psoriatic arthritis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Lupus (SLE) · Hidradenitis suppurativa · Chronic hives (urticaria) · Alopecia areata
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.